PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2011 | 71 | 1 |
Tytuł artykułu

Stroke induced brain changes:implications for stem cell transplantation

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Ischemic stroke remains a major health problem associated with high mortality and severe morbidity. In spite of the extensive research in the field of stroke biology, there is little effective treatment for a completed disease onset. Numerous neuroprotective strategies have failed in clinical trials because of lack of efficacy or unacceptable side-effects. The challenge of clinical trial design is now to understand the process leading to ischemic brain injury and thus identify the targets for intervention in stroke. Therefore, uncovering cellular and molecular processes involved in ischemic brain injury is of critical importance. The review discusses the current understanding of these processes engaged in pathogenesis of stroke including excitotoxicity and inflammation. In addition recruitment of endogenous progenitors engaged in neurogenesis and vascular regeneration has been implicated. All of the aforementioned changes opted for therapeutic intervention to protect neurons in the region adjacent to the ischemic cerebral tissue and enhance cell recovery. Stem cell transplantation seems to offer a major promise of this therapy in stroke disorders.
Słowa kluczowe
Wydawca
-
Rocznik
Tom
71
Numer
1
Opis fizyczny
p.74-85,fig.,ref.
Twórcy
autor
  • Mossakowski Medical Research Center, NeuroRepair Department, Polish Academy of Sciences, Warsaw, Poland
autor
  • Mossakowski Medical Research Center, NeuroRepair Department, Polish Academy of Sciences, Warsaw, Poland
Bibliografia
  • Akdis CA, Blesken T, Akdis M, Wüthrich B, Blaser K (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102: 98-106.
  • Allen CL, Bayraktutan U (2008) Risk factors for ischaemic stroke. Int J Stroke 3:105-116.
  • Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate- induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15: 961-973.
  • Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8: 963-970.
  • Baldauf K, Reymann KG (2005) Influence of EGF/bFGF treat­ment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res 1056: 158-167.
  • Banwell V, Sena ES, Macleod MR (2009) Systematic review and stratified meta-analysis of the efficacy of interleu- kin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis 18: 269-276.
  • Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19: 819-834.
  • Becker K, Kindrick D, Relton J, Harlan J, Winn R (2001) Antibody to the alpha4 integrin decreases infarct size in tran­sient focal cerebral ischemia in rats. Stroke 32: 206-211.
  • Benavides A, Pastor D, Santos P, Tranque P, Calvo S (2005) CHOP plays a pivotal role in the astrocyte death induced by oxygen and glucose deprivation. Glia 52: 261-275.
  • Besancon E, Guo S, Lok J, Tymianski M, Lo EH (2008) Beyond NMDA and AMPA glutamate receptors: emerg­ing mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 29: 268-227.
  • Bliss TM, Andres RH, Steinberg GK (2009) Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 37: 275-283.
  • Buhnemann C, Scholz A, Bernreuther C, Malik CY, Braun H, Schachner M, Reymann KG, Dihne M (2006) Neuronal differentiation of transplanted embryonic stem cell-de­rived precursors in stroke lesions of adult rats. Brain 129: 3238-3248.
  • Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC (2006) CNS immune privilege: hiding in plain sight. Immunol Rev 213: 48-65.
  • Chiaretti A, Antonelli A, Genovese O, Pezzotti P, Rocco CD, Viola L, Riccardi R (2008) Nerve growth factor and dou- blecortin expression correlates with improved outcome in children with severe traumatic brain injury. J Trauma 65: 80-85.
  • Choi DW and Rothman SM (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 13: 171-182.
  • Chopp M, Li Y, Jiang N, Zhang RL, Prostak J (1997) Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 16: 578-584.
  • Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008) Interleukin-lbeta and tumor necrosis factor-alpha are expressed by differ­ent subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 23: 5-46.
  • Dempsey RJ, Kalluri HS (2007) Ischemia-induced neuro­genesis: role of growth factors. Neurosurg Clin N Am 18: 183-190.
  • Denes A, Thornton P, Rothwell NJ, Allan SM (2010) Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 24: 708-723.
  • Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397.
  • Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflamma­tion and adult neurogenesis: the dual role of microglia. Neuroscience 158: 1021-1029.
  • Espinoza-Rojo M, Iturralde-Rodriguez KI, Chanez-Cardenas ME, Ruiz-Tachiquin ME, Aguilera P (2010) Glucose trans­porters regulation on ischemic brain: Possible role of therapeu­tic target. Cent Nerv Syst Agents Med Chem 10: 317-325.
  • Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK (1995) Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res 30: 125-130.
  • Feeney CJ and Stys PK (2009) Astrocyte: Response to injury. Encyclopedia of Neuroscience 587-593 DOI 10 1016/B978-008045046-9.00998-0.
  • Feigin VL (2005) Stroke epidemiology in the developing world. Lancet 365: 2160-2161.
  • Figiel I (2008) Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol Exp (Wars) 68: 526-534.
  • Fukuda S, Abematsu M, Mori H, Yanagisawa M, Kagawa T, Nakashima K, Yoshimura A, Taga T (2007) Potentiation of astrogliogenesis by STAT3-mediated activation of bone morphogenetic protein-Smad signaling in neural stem cells. Mol Cell Biol 27: 4931-4937.
  • Gary DS, Bruce-Keller AJ, Kindy MS, Mattson MP (1998) Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 18: 1283-1287.
  • Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R, Ludolph AC, Reske SN (2000) In vivo imag­ing of activated microglia using [11C]PK11195 and posi­tron emission tomography in patients after ischemic stroke. Neuroreport 11: 2957-2960.
  • Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G, Ongini E (2000) Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci 12: 2265-2272.
  • Hankey GJ (2006) Potential new risk factors for ischemic stroke: what is their potential? Stroke 37: 2181-2188.
  • Haas S, Weidner N, Winkler J (2005) Adult stem cell therapy in stroke. Curr Opin Neurol 18: 59-64.
  • Hicks A, Jolkkonen J (2009) Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol Exp (Wars) 69: 1-11.
  • Huang J, Upadhyay UM, Tamargo RJ (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66: 232-245.
  • Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, Offner H (2007) T- and B-cell- deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 27: 1798-1805.
  • Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, Frenkel D, Li J, Sidman RL, Walsh CA, Snyder EY, Khoury SJ (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 101: 18117-18122.
  • Jablonska A, Kozlowska H, Markiewicz I, Domanska-Janik K, Lukomska B (2010) Transplantation of neural stem cells derived from human cord blood to the brain of adult and neonatal rats. Acta Neurobiol Exp (Wars) 70: 337-350
  • Janowski M, Gornicka-Pawlak E, Kozlowska H, Domanska- Janik K, Gielecki J, Lukomska B (2008) Structural and functional characteristic of a model for deep-seated lacu- nar infarct in rats. J Neurol Sci 273: 40-48.
  • Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 99: 11946-11950.
  • Kalluri HS, Dempsey RJ (2008) Growth factors, stem cells, and stroke. Neurosurg Focus 24: E14.
  • Kawai T, Takagi N, Miyake-Takagi K, Okuyama N, Mochizuki N, Takeo S (2004) Characterization of BrdU-positive neu­rons induced by transient global ischemia in adult hip­pocampus. J Cereb Blood Flow Metab 24: 548-555.
  • Kita T, Liu L, Tanaka N, Kinoshita Y (1997) The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury. Int J Legal Med 110: 305-311.
  • Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kämpgen E, Romani N, Schuler G (1997) High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregula- tion by IL-4 and IL-10. J Exp Med 184: 741-746.
  • Kochanek PM, Hallenbeck JM (2010) Polymorphonuclear leukocytes and monocytes/macrophages in the pathogen­esis of cerebral ischemia and stroke. Stroke 23: 1367­1379.
  • Koenigsknecht J, Landreth G (2004) Microglial phagocyto­sis of fibrillar beta-amyloid through a beta1 integrin-de- pendent mechanism. J Neurosci 24: 9838-9846.
  • Koizumi H, Higginbotham H, Poon T, Tanaka T, Brinkman BC, Gleeson JG (2006) Doublecortin maintains bipolar shape and nuclear translocation during migration in the adult forebrain. Nat Neurosci 9: 779-786.
  • Koketsu D, Furuichi Y, Maeda M, Matsuoka N, Miyamoto Y, Hisatsune T (2006) Increased number of new neurons in the olfactory bulb and hippocampus of adult non-hu­man primates after focal ischemia. Exp Neurol 199: 92-102.
  • Lakhan SE, Kirchgessner A, Hofer M (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 17: 7-97.
  • Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B (2009) Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 29: 1319-1330.
  • Lee JS, Hong JM, Choi JY, Park J, Lee G, Ahn YH, Lee PH, Kang YM, Kim HS, Li, Lee MA, Woo SY, Moon GJ, Bang OY (2010) A long-term follow-up study of intrave­nous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28: 1099­1106.
  • Liew FY, Xu D, Brint EK, O'Neill LA (2005) Negative regulation of toll-like receptor-mediated immune respons­es. Nat Rev Immunol 5: 446-458.
  • Lindvall O, Kokaia Z (2010) Stem cells in human neurode­generative disorders--time for clinical translation? J Clin Invest 120: 29-40.
  • Liu J, Solway K, Messing RO, Sharp FR (1998) Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 18: 7768-7778.
  • Liu P, Xu B, Spokas E, Lai PS, Wong PY (2000) Role of endogenous nitric oxide in TNF-alpha and IL-1beta gen­eration in hepatic ischemia-repefusion Shock. 13: 217­223.
  • Liu W, Hendren J, Qin XJ, Shen J, Liu KJ (2009b) Normobaric hyperoxia attenuates early blood-brain bar­rier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J Neurochem 108: 811-820.
  • Liu Y, Teige I, Birnir B, Issazadeh-Navikas S (2006) Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 12: 518-525.
  • Liu YP, Lang BT, Baskaya MK, Dempsey RJ, Vemuganti R (2009) The potential of neural stem cells to repair stroke- induced brain damage. Acta Neuropathol 117: 469-480.
  • Lo EH, Dalkara T, Moskowitz MA (2003) Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415.
  • Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, Bresolin N, Comi GP, Corti S (2008) Stem cell therapy in stroke. Cell Mol Life Sci 66: 757-772.
  • Lu KT, Wang YW, Wo YY, Yang YL (2005) Extracellular signal regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett 386: 40-45.
  • Luo Y (2010) Cell-based therapy for stroke. J Neural Transm DOI 10.1007/s00702-010-0478-4.
  • Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147: S232-S240.
  • Majka M, Janowska-Wieczorek A, Ratajczak J, Ehrenman K, Pietrzkowski Z, Kowalska MA, Gewirtz AM, Emerson SG, Ratajczak MZ (2001) Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and mega- karyoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97: 3075-3085.
  • Markiewicz I, Lukomska B (2006) The role of astrocytes in the physiology and pathology of the central nervous sys­tem. Acta Neurobiol Exp (Wars) 66(4):343-358
  • McColl BW, Rothwell NJ, Allan SM (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 28: 9451-9462.
  • Minger SL, Ekonomou A, Carta EM, Chinoy A, Perry RH, Ballard CG (2007) Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2: 69-74.
  • Muir KW, Tyrrell P, Sattar N, Warburton E (2007) Inflammation and ischaemic stroke. Curr Opin Neurol 20:334-342.
  • Murdoch I, Perry EK, Court JA, Graham DI, Dewar D (1998) Cortical cholinergic dysfunction after human head injury. J Neurotrauma 15: 295-305.
  • Nakajima K, Kohsaka S (2004) Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 4: 65-84.
  • Nawashiro H, Martin D, Hallenbeck JM (1997) Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 778: 265-271.
  • Ooboshi H, Ibayashi S, Shichita T, Kumai Y, Takada J, Ago T, Arakawa S, Sugimori H, Kamouchi M, Kitazono T, Iida M (2005) Postischemic gene transfer of interleukin- 10 protects against both focal and global brain ischemia. Circulation 111: 913-919.
  • Owens T, Bechmann I, Engelhardt B (2008) Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 67: 1113-1121.
  • Pickering M, Cumiskey D, O'Connor JJ (2005) Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90: 663-670.
  • Pryce G, Baker D (2007) Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabi- noid receptors. Br J Pharmacol 150: 519-525.
  • Rothwell NJ (1999) Cytokines - killers in the brain? J Physiol 514: 3-17.
  • Ruhul Amin AR, Senga T, Oo ML, Thant AA, Hamaguchi M (2003) Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signaling pathways, Akt and Erk. Genes Cells 8: 515­523.
  • Schâbitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A, Kuhn HG (2007) Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38: 2165-2172.
  • Schilling M, Besselmann M, Leonhard C, Mueller M, Ringelstein EB, Kiefer R (2003) Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluo­rescent protein transgenic bone marrow chimeric mice. Exp Neurol 183: 25-33.
  • Semenov DG, Samoilov MO, Lazarewicz JW (2008) Preconditioning reduces hypoxia-evoked alterations in glutamatergic Ca2+ signaling in rat cortex. Acta Neurobiol Exp (Wars) 68: 169-179.
  • Shin HY, Kim JH, Phi JH, Park CK, Kim JE, Kim JH, Paek SH, Wang KC, Kim DG (2008) Endogenous neurogenesis and neovascularization in the neocortex of the rat after focal cerebral ischemia. J Neurosci Res 86: 356-367.
  • Sims NR, Muyderman H (2010) Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 1802: 80-91.
  • Somera-Molina KC, Nair S, Van Eldik LJ, Watterson DM, Wainwright MS (2009) Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a 'two-hit' seizure model. Brain Res 1282: 162-172.
  • Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998) IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251: 189-192.
  • Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel- Poore MP (2002) The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 932: 110-119.
  • Taoufik E, Probert L (2008) Ischemic neuronal damage. Curr Pharm Des 14: 3565-3573.
  • Teng H, Zhang ZG, Wang L, Zhang RL, Zhang L, Morris D, Gregg SR, Wu Z, Jiang A, Lu M, Zlokovic BV, Chopp M (2008) Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab 28: 764-771.
  • Thornton P, Pinteaux E, Allan SM, Rothwell NJ (2008) Matrix metalloproteinase-9 and urokinase plasminogen activator mediate interleukin-1-induced neurotoxicity. Mol Cell Neurosci 37: 135-142.
  • Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, Darsalia V, Ekdahl CT, Kokaia Z, Lindvall O (2006) Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24: 739-747.
  • Tian L, Rauvala H, Gahmberg CG (2009) Neuronal regula­tion of immune responses in the central nervous system. Trends Immunol 30: 91-99.
  • Tureyen K, Vemuganti R, Bowen KK, Sailor KA, Dempsey RJ (2005) EGF and FGF-2 infusion increases post-isch- emic neural progenitor cell proliferation in the adult rat brain. Neurosurgery 57: 1254-1263.
  • Vandeputte C, Thomas D, Dresselaers T, Crabbe A, Verfaillie C, Baekelandt V, Van Laere K, Himmelreich U (2010) Characterization of the inflammatory response in a pho- tothrombotic stroke model by MRI: implications for stem cell transplantation. Mol Imaging Biol 2010 DOI 10.1007/ s11307-010-0395-9.
  • Vila N, Reverter JC, Yague J, Chamorro A (2000) Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. J Interferon Cytokine Res 20: 325-329.
  • Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A (2003) Levels of anti-inflammatory cytokines and neurologi­cal worsening in acute ischemic stroke. Stroke 34: 671-675.
  • Vogelgesang A, May VE, Grunwald U, Bakkeboe M, Langner S, Wallaschofski H, Kessler C, Bröker BM, Dressel A (2010) Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 5: e8718.
  • de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209­1220.
  • Wachs FP, Winner B, Couillard-Despres S, Schiller T, Aigner R, Winkler J, Bogdahn U, Aigner L (2006) Transforming growth factor-beta1 is a negative modula­tor of adult neurogenesis. J Neuropathol Exp Neurol 65: 358-370.
  • Wang Y, Qin ZH (2010) Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15: 1382-1402.
  • Watanabe T, Okuda Y, Nonoguchi N, Zhao MZ, Kajimoto Y, Furutama D, Yukawa H, Shibata MA, Otsuki Y, Kuroiwa T, Miyatake S (2004) Postischemic intraventricular administration of FGF-2 expressing adenoviral vectors improves neurologic outcome and reduces infarct volume after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 24: 1205-1213.
  • Wilde GJ, Pringle AK, Sundstrom LE, Mann DA, Iannotti F (2000) Attenuation and augmentation of ischaemia-relat- ed neuronal death by tumour necrosis factor-alpha in vitro. Eur J Neurosci 12: 3863-3870.
  • Williams K, Dooley N, Ulvestad E, Becher B, Antel JP (1996) IL-10 production by adult human derived micro- glial cells. Neurochem Int 29: 55.
  • Wojcik L, Sawicka A, Rivera S, Zalewska T (2009) Neurogenesis in gerbil hippocampus following brain ischemia: focus on the involvement of metalloproteinas- es. Acta Neurobiol Exp (Wars) 69: 52-61.
  • Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflamma­tory responses. J Clin Invest 101: 311-320.
  • Yagita Y, Kitagawa K, Ohtsuki T, Takasawa K, Miyata T, Okano H, Hori M, Matsumoto M (2001) Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke 32: 1890-1896.
  • Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697­709.
  • Zhang RL, LeTourneau Y, Gregg SR, Wang Y, Toh Y, Robin AM, Zhang ZG, Chopp M (2007) Neuroblast division during migration toward the ischemic striatum: a study of dynamic migratory and proliferative characteristics of neuroblasts from the subventricular zone. J Neurosci 27: 3157-3162.
  • Zhang RL, Zhang ZG, Zhang L, Chopp M (2001) Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 105: 33-41.
  • Zhao Y, Rempe DA (2010) Targeting astrocytes for stroke therapy. Neurotherapeutic 7: 439-451.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-68923166-6b4e-4ef0-93f3-690302e9500f
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.